2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate

C25H30N4O5 — CID 10115878

IUPAC2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate
SMILESCC(=O)OCCOc1cccc(Nc2ncc(CO)c(-c3c(C4CCCCC4)noc3C)n2)c1
InChIInChI=1S/C25H30N4O5/c1-16-22(24(29-34-16)18-7-4-3-5-8-18)23-19(15-30)14-26-25(28-23)27-20-9-6-10-21(13-20)33-12-11-32-17(2)31/h6,9-10,13-14,18,30H,3-5,7-8,11-12,15H2,1-2H3,(H,26,27,28)
InChIKeyKCBMNHHAUSUYOH-UHFFFAOYSA-N
MW466.54 g/mol
LogP4.67
Rot. Bonds9

About 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate

2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate (PubChem CID 10115878) has the molecular formula C25H30N4O5 and a molecular weight of 466.54 g/mol. Its IUPAC name is 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate.

Molecular Properties

Compound Name2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate
PubChem CID10115878
Molecular FormulaC25H30N4O5
Molecular Weight466.54 g/mol
Exact Mass466.22
IUPAC Name2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate
SMILESCC(=O)OCCOc1cccc(Nc2ncc(CO)c(-c3c(C4CCCCC4)noc3C)n2)c1
InChIInChI=1S/C25H30N4O5/c1-16-22(24(29-34-16)18-7-4-3-5-8-18)23-19(15-30)14-26-25(28-23)27-20-9-6-10-21(13-20)33-12-11-32-17(2)31/h6,9-10,13-14,18,30H,3-5,7-8,11-12,15H2,1-2H3,(H,26,27,28)
InChIKeyKCBMNHHAUSUYOH-UHFFFAOYSA-N
XLogP4.67
TPSA119.60 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500466.54
LogP ≤ 54.67
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate?
The IUPAC name of 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate (CID 10115878) is 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate.
What is the SMILES notation for 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate?
The canonical SMILES for 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate is CC(=O)OCCOc1cccc(Nc2ncc(CO)c(-c3c(C4CCCCC4)noc3C)n2)c1.
What is the InChIKey of 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate?
The InChIKey is KCBMNHHAUSUYOH-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H30N4O5/c1-16-22(24(29-34-16)18-7-4-3-5-8-18)23-19(15-30)14-26-25(28-23)27-20-9-6-10-21(13-20)33-12-11-32-17(2)31/h6,9-10,13-14,18,30H,3-5,7-8,11-12,15H2,1-2H3,(H,26,27,28).
What are the key properties of 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate?
2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate has a molecular weight of 466.54 g/mol, XLogP of 4.67, 9 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[[4-(3-cyclohexyl-5-methyl-1,2-oxazol-4-yl)-5-(hydroxymethyl)pyrimidin-2-yl]amino]phenoxy]ethyl acetate is sourced from PubChem (CID 10115878), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).